Research reading
Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale demand and the Canada (CAN) to Switzerland (CHE) lane
Switzerland (CHE) reported $9.1M of medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale imports in 2024. Canada (CAN) accounted for 0% of the observed market and reported $2.8K in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +9.7% buyer growth and +14.9% exporter growth. The page separates reported values from projections and indicators.
